Rosen Law Firm Investigates Disc Medicine, Inc. Securities Class Action Claims
Rosen Law Firm is investigating potential securities claims on behalf of Disc Medicine, Inc. shareholders. The investigation concerns allegations that Disc Medicine may have issued materially misleading statements.
New York – Aug. 22, 2026 – Rosen Law Firm, a global investor rights law firm, is continuing its investigation into potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON). The probe stems from allegations that Disc Medicine may have issued materially misleading or false statements that impacted the company's stock price.
Rosen Law Firm is encouraging all investors who have suffered significant losses and/or who are aware of potentially misleading information related to Disc Medicine to contact the firm. The investigation aims to determine if the company's actions violated securities laws and if shareholders are entitled to damages.
The firm has a history of pursuing securities litigation and aims to ensure investors' rights are protected.